Chris Sander is Professor for cell biology at Harvard Medical School and an internationally recognized expert in computer-assisted cancer research as well as the founder of perturbation biology - a field that seeks to predict the responses of cells to certain disorders using computer simulations. Over the next few years, Chris Sanders newly established research group in Berlin will take advantage of the possibilities of this area in order to be able to assess and individually improve the efficacy of drugs in the treatment of different tumors. For this purpose, organoids from tissue samples of cancer patients will be generated and, afterwards, analized as well as simulated for their treatment options down to the level of single cells. Sanders hosting partner will be bioinformatics Professor Nils Blüthgen of the Institute of Pathology of the Charité. On the part of the Max Delbrück Center for Molecular Medicine, the cell biologist Professor Markus Landthaler will hold a share on the project.
More about Chris Sander
Read Chris Sander's contribution "Block the exit doors" about mutations in cancer cells that escape therapy in our series "Elephants & Butterflies - Science in a nutshell".
Or listen to Chris Sander on "AskDifferent," the Einstein Foundation podcast in the episode "Mapping the Labyrinth" about his research to prevent these cancer cells from escaping therapy through side doors.
Photo: Chris Sander/ Sanderlab.org
Short Vita
Since 2019
Einstein Visiting Fellow at Berlin Institute of Health, Germany
Since 2016
Professor of Cell Biology at Harvard Medical School, USA
Director of the cBio Center at Dana-Farber Cancer Institute, USA
Associate Member of the Broad Institute, USA
Previously
Chair of the Computational Biology Programme at the Memorial Sloan–Kettering Cancer Center, USA
1975
PhD Degree in theoretical physics from the State University of New York, USA
Follow us on